Molina Healthcare (MOH)
(Delayed Data from NYSE)
$325.43 USD
-4.87 (-1.47%)
Updated Oct 10, 2024 04:00 PM ET
After-Market: $325.43 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$325.43 USD
-4.87 (-1.47%)
Updated Oct 10, 2024 04:00 PM ET
After-Market: $325.43 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth D Momentum D VGM
Zacks News
Why Molina (MOH) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Molina (MOH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
4 Solid Liquid Stocks to Build a Winning Portfolio
by Zacks Equity Research
Focus on four top-ranked liquid stocks that are poised to reap marvelous returns.
3 Health-Insurance Stocks to Consider When the Fed Drops Rates
by Mitchell Moore
The next Federal Reserve Open Market Committee meeting is set for July 30-31, where they will decide whether or not to cut interest rates. The market assumes a 100% probability that the Fed cuts rates by at least a quarter point, according to analysts.
Ensign Group Surges 51.8% in a Year: More Room for Upside?
by Zacks Equity Research
Ensign Group's (ENSG) inorganic growth strategies should lead to healthy revenues. This will likely bump up its share price further.
Molina (MOH) Stock Surges 34% in a Year: More Room to Run
by Zacks Equity Research
Molina's (MOH) restructuring plan should aid revenue growth. This will likely drive its share price further.
Top Ranked Growth Stocks to Buy for July 9th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 9th
UnitedHealth's Stock Down in 1H19: What Lies Ahead in 2H?
by Zacks Equity Research
Regulatory disturbances weigh on UnitedHealth's (UNH) stock in the first half of 2019. However, the company is likely to get support from its strong business model.
3 Healthcare Stocks to Stay on Your Watch List for 2H19
by Zacks Equity Research
Banking on Medicaid and Medicare business, these three stocks should remain in your focus for the second half of 2019.
HCA Healthcare Buys Urgent Care Centers to Boost Portfolio
by Zacks Equity Research
HCA Healthcare (HCA) acquires urgent care centers in Austin, Dallas and Houston to enhance its portfolio.
Ensign Group (ENSG) Hits 52-Week High, Can the Run Continue?
by Zacks Equity Research
Ensign Group (ENSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
Molina (MOH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Molina (MOH) closed at $142.87, marking a +1.08% move from the previous day.
Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina
by Zacks Equity Research
Zacks.com featured highlights include: BioDelivery, Ciena, United States and Molina
Should Value Investors Buy Molina (MOH) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
UnitedHealth to Buy Equian & Foray into Healthcare Payments
by Zacks Equity Research
UnitedHealth (UNH) is mulling to buy Equian and enter into the expanding healthcare payments space, as per sources.
Moving Average Crossover Alert: Molina Healthcare
by Zacks Equity Research
Molina Healthcare, Inc. (MOH) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.
Focus on 4 Liquid Picks on the Top Rung for Robust Returns
by Zacks Equity Research
Here are four top-ranked liquid stocks that investors can cling on to for significant returns.
Zacks.com featured highlights include: Brinker, Sonic Automotive, Molina, American Financial and Invitation Homes
by Zacks Equity Research
Zacks.com featured highlights include: Brinker, Sonic Automotive, Molina, American Financial and Invitation Homes
5 Best GARP Stocks With Discounted PEG
by Urmimala Biswas
A lower PEG ratio, preferably less than 1, is always better for GARP investors.
Tenet Healthcare Strikes Deal for Revenue Cycle Management
by Zacks Equity Research
Tenet Healthcare's (THC) subsidiary Conifer forms a new revenue cycle management alliance with a member of D-HH.
Upgraded Broker Ratings Make These 5 Stocks Worth Betting on
by Swayta Shah
After thorough research, brokers decide to rate a particular company's stock. So, when a broker upgrades a stock, one can rely on it.
Why Should You Add Magellan Health to Your Portfolio?
by Zacks Equity Research
Banking high on wise strategic measures and a favorable operating performance, Magellan Health (MGLN) can be added to your portfolio.
Trade Negotiations Can Work or Fail
by John Blank
Two clean tracks set the event risk.
Molina (MOH) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Molina (MOH) closed the most recent trading day at $146.37, moving +0.36% from the previous trading session.
Why it is Worth Betting on Cigna Stock for Your Portfolio
by Zacks Equity Research
Banking on prudent buyouts and solid overseas business, Cigna (CI) holds immense potential to reap benefits for investors.